Suppr超能文献

化学策略增强癌症疫苗。

Chemical Strategies to Boost Cancer Vaccines.

机构信息

Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, 100084 Beijing, China.

Beijing Institute for Brain Disorders, 100069 Beijing, China.

出版信息

Chem Rev. 2020 Oct 28;120(20):11420-11478. doi: 10.1021/acs.chemrev.9b00833. Epub 2020 Sep 11.

Abstract

Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV strategy modulates the innate and adaptive immune systems with broader activation to redeploy antitumor immunity with individualized tumor-specific antigens (neoantigens). Following a sequential scheme of tumor biopsy, mutation analysis, and epitope prediction, the administration of neoantigens with synthetic long peptide (SLP) or mRNA formulations dramatically improves the population and activity of antigen-specific CD4+ and CD8+ T cells. Despite the promising prospect of PCVs, there is still great potential for optimizing prevaccination procedures and vaccine potency. In particular, the arduous development of tumor-associated antigen (TAA)-based vaccines provides valuable experience and rational principles for augmenting vaccine potency which is expected to advance PCV through the design of adjuvants, delivery systems, and immunosuppressive tumor microenvironment (TME) reversion since current personalized vaccination simply admixes antigens with adjuvants. Considering the broader application of TAA-based vaccine design, these two strategies complement each other and can lead to both personalized and universal therapeutic methods. Chemical strategies provide vast opportunities for (1) exploring novel adjuvants, including synthetic molecules and materials with optimizable activity, (2) constructing efficient and precise delivery systems to avoid systemic diffusion, improve biosafety, target secondary lymphoid organs, and enhance antigen presentation, and (3) combining bioengineering methods to innovate improvements in conventional vaccination, "smartly" re-educate the TME, and modulate antitumor immunity. As chemical strategies have proven versatility, reliability, and universality in the design of T cell- and B cell-based antitumor vaccines, the union of such numerous chemical methods in vaccine construction is expected to provide new vigor and vitality in cancer treatment.

摘要

个体化癌症疫苗(PCV)正在为癌症免疫治疗中重新激发疫苗策略。与过继性 T 细胞治疗和检查点阻断不同,PCV 策略通过广泛激活先天和适应性免疫系统,用个体化肿瘤特异性抗原(新抗原)重新部署抗肿瘤免疫。在肿瘤活检、突变分析和表位预测的序贯方案之后,用合成长肽(SLP)或 mRNA 制剂给予新抗原,可显著提高抗原特异性 CD4+和 CD8+T 细胞的数量和活性。尽管 PCV 前景广阔,但仍有很大的潜力来优化疫苗接种前的程序和疫苗效力。特别是,肿瘤相关抗原(TAA)为基础的疫苗的艰难发展为增强疫苗效力提供了宝贵的经验和合理的原则,预计通过设计佐剂、传递系统和免疫抑制性肿瘤微环境(TME)逆转来推进 PCV,因为目前的个体化疫苗只是将抗原与佐剂混合。考虑到 TAA 为基础的疫苗设计的更广泛应用,这两种策略相辅相成,可以导致个性化和通用的治疗方法。化学策略为以下方面提供了广阔的机会:(1)探索新型佐剂,包括具有可优化活性的合成分子和材料;(2)构建高效精确的传递系统,以避免全身扩散、提高生物安全性、靶向次级淋巴器官和增强抗原呈递;(3)结合生物工程方法对传统疫苗进行创新改进,“智能”重新教育 TME,并调节抗肿瘤免疫。由于化学策略在设计 T 细胞和 B 细胞为基础的抗肿瘤疫苗方面已经证明了多功能性、可靠性和通用性,因此在疫苗构建中结合如此众多的化学方法有望为癌症治疗提供新的活力和生命力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验